Reduced posterior cingulate binding of I-123 iodo-dexetimide to muscarinic receptors in mild Alzheimer's disease

Journal of Clinical Neuroscience

Volumn 12, Issue 4, 2005, Pages 421-425

  Boundy, K L ^a   Barnden, L R ^a   Katsifis, A G ^b   Rowe, C C ^c  

^a QUEEN ELIZABETH HOSPITAL   (Australia)

^b AUSTRALIAN NUCLEAR SCIENCE AND TECHNOLOGY ORGANISATION   (Australia)

^c AUSTIN HEALTH   (Australia)

Author keywords

Iodo dexetimide; Mild Alzheimer's disease; Muscarinic receptors; Posterior cingulate

Indexed keywords

HEXAMETHYLPROPYLENE AMINE OXIME TECHNETIUM TC 99M; IODODEXETIMIDE I 123; MUSCARINIC RECEPTOR; RADIOPHARMACEUTICAL AGENT; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; ARTICLE; BRAIN ATROPHY; BRAIN BLOOD FLOW; BRAIN PERFUSION; CINGULATE GYRUS; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; MINI MENTAL STATE EXAMINATION; PRIORITY JOURNAL; RATING SCALE; RECEPTOR BINDING; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

ALZHEIMER DISEASE; BRAIN MAPPING; CASE-CONTROL STUDIES; DEXETIMIDE; FEMALE; FOLLOW-UP STUDIES; GYRUS CINGULI; HUMANS; IODINE ISOTOPES; MALE; MUSCARINIC ANTAGONISTS; RECEPTORS, MUSCARINIC; SEVERITY OF ILLNESS INDEX; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 19744369068     PISSN: 09675868     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jocn.2004.06.012     Document Type: Article

References (48)

1. E. Perry, R. Perry, R. Gibson, G. Blessed, and B. Tomlinson A cholinergic connection between normal aging and senile dementia in the human hippocampus Neurosci Lett 6 1977 85 89
2. P. Davies, and A. Maloney Selective loss of central cholinergic neurons in Alzheimer's disease Lancet 11 1976 1403
3. P. White, C.R. Hiley, and M.J. Goodhardt Neocortical cholinergic neurons in elderly people Lancet 1 8013 1977 668 671
4. D.M. Araujo, P.A. Lapchak, Y. Robitaille, S. Gauthier, and R. Quirion Differential alteration of various cholinergic markers in cortical and subcortical regions of human brain in Alzheimer's disease J Neurochem 50 1988 1914 1923
5. C. Geula, and M.M. Mesulam Systematic regional variations in the loss of cortical cholinergic fibers in Alzheimer's disease Cerebral Cortex 6 1996 165 177
6. C. Geula, M.M. Mesulam, D.M. Saroff, and C.K. Wu Relationship between plaques, tangles, and loss of cortical cholinergic fibers in Alzheimer disease J Neuropathol Exp Neurol 57 1998 63 75
7. P. Giannakopoulos, P.R. Hof, A.S. Giannakopoulos, F.R. Herrmann, J.P. Michel, and C. Bouras Regional distribution of neurofibrillary tangles and senile plaques in the cerebral cortex of very old patients Arch Neurol 52 1995 1150 1159
8. W. Lang, and H. Henke Cholinergic receptor binding and autoradiography in brains of non-neurological and senile dementia of Alzheimer type patients Brain Res 267 1983 271 280
9. D.M. Bowen, S.J. Allen, and J.S. Benton Biochemical assessment of serotonergic and cholinergic dysfunction and cerebral atrophy in Alzheimer's disease J Neurochem 41 1983 266 272
10. B.A. Vogt, P.B. Crino, and L. Volicer Laminar alterations in gamma-aminobutyric acid A, muscarinic, and beta adrenoceptors and neuron degeneration in cingulate cortex in Alzheimer's disease J Neurochem 57 1991 282 290
11. B.A. Vogt, P.B. Crino, and L.J. Vogt Reorganization of cingulate cortex in Alzheimer's disease: neuron loss, neuritic plaques, and muscarinic receptor binding Cerebral Cortex 2 1992 526 535
12. M. Li, R.P. Yasuda, S.J. Wall, A. Wellstein, and B.B. Wolfe Distribution of m2 muscarinic receptors in rat brain using antisera selective for m2 receptors Mol Pharmacol 40 1991 28 35
13. R. Quirion, I. Aubert, and P.A. Lapchak Muscarinic receptor subtypes in human neurodegenerative disorders: focus on Alzheimer's disease Trends Pharmacol Sci Suppl 1989 80 84
14. R. Quirion Cholinergic markers in Alzheimer disease and the autoregulation of acetylcholine release J Psychiat Neurosci 18 1993 226 234
15. A. Wilson, R. Dannals, H. Ravert, J. Frost, and H. Wagner Synthesis and biological evaluation of 123I and 124I-iododexetimide, a potent muscarinic cholinergic receptor antagonist J Med Chem 32 1989 1057 1062
16. K. Boundy, L. Barnden, and C. Rowe Human dosimetry and normal brain distribution of iodine-123-iododexetimide: a SPECT imaging agent for cholinergic muscarinic neuroreceptors J Nucl Med 36 1995 1332 1338
17. J.J. Claus, E.A. Dubois, and J. Booij Demonstration of a reduction in muscarinic receptor binding in early Alzheimer's disease using iodine-123 dexetimide single photon emission computed tomography Eur J Nucl Med 24 1997 602 608
18. K. Boundy, C. Rowe, and M. Reid Comparison of cholinergic neuroreceptor SPECT with 123I-iododexetimide and Tc-99m HMPAO in the early diagnosis of Alzheimer's disease P. De Deyn R. Dierckx A. Alavi B. Pickut A textbook of SPECT in neurology and psychiatry 1997 John Libbey London 19 26
19. 11C-N-methyl-4-piperidyl benzilate: comparison with cerebral blood flow and cerebral glucose metabolism Ann Nucl Med 12 1998 35 42
20. B.L. Holman, R.E. Gibson, T.C. Hill, W.C. Eckelman, M. Albert, and R.C. Reba Muscarinic acetylcholine receptors in Alzheimer's disease JAMA 254 1985 3063 3066
21. D.J. Wyper, D. Brown, and J. Patterson Deficits in iodine-labelled 3-quinuclidinyl benzilate binding in relation to cerebral blood flow in patients with Alzheimer's disease Eur J Nucl Med 20 1993 379 386
22. D.R. Weinberger, R. Gibson, and R. Coppola The distribution of cerebral muscarinic receptors in-vivo in the patients with dementia Arch Neurol 48 1991 169 176
23. D.R. Weinberger, D. Jones, and R.C. Reba A comparison of FDG PET and IQNB SPECT in normal subjects and in patients with dementia J Neuropsychiatry Clin Neurosci 4 1992 239 248
24. A. Brun, and E. Englund Regional pattern of degeneration in Alzheimer's disease: neuronal loss and histopathological grading Histopathology 5 1981 549 564
25. P. Giannakopoulos, P. Hof, J. Michel, J. Guimon, and C. Bouras Cerebral cortex pathology in aging and Alzheimer's disease: a quantitative survey of large hospital-based geriatric and psychiatric cohorts Brain Res 25 1997 217 245
26. X. Liu, C. Erikson, and A. Brun Cortical synaptic changes and gliosis in normal aging, Alzheimer's disease and frontal lobe degeneration Dementia 7 1996 128 134
27. S. Minoshima, N.L. Foster, and D.E. Kuhl Posterior cingulate cortex in Alzheimer's disease [letter] Lancet 344 8926 1994 895
28. E.M. Reiman, R.J. Caselli, and L.S. Yun Preclinical evidence of Alzheimer's disease in persons homozygous for the epsilon 4 allele for apolipoprotein E [see comments] N Engl J Med 334 1996 752 758
29. S. Minoshima, B. Giordani, S. Berent, K.A. Frey, N.L. Foster, and D.E. Kuhl Metabolic reduction in the posterior cingulate cortex in very early Alzheimer's disease Ann Neurol 42 1997 85 94
30. K. Ishii, M. Sasaki, S. Yamaji, S. Sakamoto, H. Kitagaki, and E. Mori Demonstration of decreased posterior cingulate perfusion in mild Alzheimer's disease by means of H215O positron emission tomography Eur J Nucl Med 24 1997 670 673
31. Y. Kumakura, T. Momose, S. Oku, T. Ohtake, J. Nishikawa, and K. Ohtomo Stepwise analysis of cerebral blood flow SPECT imaging on standard brain atlas with dementia of Alzheimer's type Kaku Igaku 35 1998 843 848
32. N. Hirono, E. Mori, and K. Ishii Hypofunction in the posterior cingulate gyrus correlates with disorientation for time and place in Alzheimer's disease J Neurol Neurosurg Psychiatry 64 1998 552 554
33. K.A. Johnson, K. Jones, and B.L. Holman Preclinical prediction of Alzheimer's disease using SPECT Neurology 50 1998 1563 1571
34. E. Salmon, F. Collette, C. Degueldre, C. Lemaire, and G. Franck Voxel-based analysis of confounding effects of age and dementia severity on cerebral metabolism in Alzheimer's disease Human Brain Mapping 10 2000 39 48
35. V. Ibanez, P. Pietrini, and G.E. Alexander Regional glucose metabolic abnormalities are not the result of atrophy in Alzheimer's disease Neurology 50 1998 1585 1593
36. D. Kogure, H. Matsuda, and T. Ohnishi Longitudinal evaluation of early Alzheimer's disease using brain perfusion SPECT J Nucl Med 41 2000 1155 1162
37. G.W. Small, L.M. Ercoli, and D.H. Silverman Cerebral metabolic and cognitive decline in persons at genetic risk for Alzheimer's disease Proc Natl Acad Sci USA 97 2000 6037 6042
38. B.A. Vogt, E. Townes-Anderson, and D.L. Burns Dissociated cingulate cortical neurons: morphology and muscarinic acetylcholine receptor binding properties J Neurosci 7 1987 959 971
39. D.C. Mash, W.F. White, and M.M. Mesulam Distribution of muscarinic receptor subtypes within architectonic subregions of the primate cerebral cortex J Comp Neurol 278 1988 265 274
40. K. Friston, C. Frith, P. Liddle, and R. Frackowiak Comparing functional (PET) images: the assessment of significant change J Cereb Blood Flow Metab 11 1991 690 699
41. K. Friston, K. Worsley, R. Frackowiak, J. Mazziotta, and A. Evans Assessing the significance of focal activations using their spatial extent Human Brain Mapping 1 1994 214 220
42. J. Ashburner, P. Neelin, D. Collins, A. Evans, and K. Friston Incorporating prior knowledge into image registration Neuroimage 6 1997 344 352
43. J. Ashburner, and K. Friston Nonlinear spatial normalization using basis functions Human Brain Mapping 7 1999 254 266
44. J. Talairach, and P. Tournoux Co-planar stereotactic atlas of the human brain 1988 Thieme Stuttgart
45. B.A. Vogt, L.J. Vogt, and K.E. Vrana Multivariate analysis of laminar patterns of neurodegeneration in posterior cingulate cortex in Alzheimer's disease Exp Neurol 153 1998 8 22
46. S.A. Farr, K. Uezu, T.A. Creonte, J.F. Flood, and J.E. Morley Modulation of memory processing in the cingulate cortex of mice Pharmacol Biochem Behavior 65 2000 363 368
47. D. Mash, D. Flynn, and L. Potter Loss of M2 muscarinic receptors in the cerebral cortex in Alzheimer's disease and experimental cholinergic denervation Science 228 1985 1115 1117
48. K.L. Boundy, L.R. Barnden, and C.C. Rowe Human dosimetry and biodistribution of iodine-123-iododexetimide: a SPECT imaging agent for cholinergic muscarinic neuroreceptors J Nucl Med 36 1995 1332 1338